Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000063

Chief Medical Officer sold 7,947 shares at an average $69.28 ($550,607)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goncalves Joana · Chief Medical Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $6.84 $23,940 37,165 D
2026-06-15 Exercise or conversion : show line 2 in the form 10b5-1 +3,500 $7.80 $27,300 40,665 D
2026-06-15 Sale : show line 3 in the form 10b5-1 −1,636 $68.38 $111,876 39,029 D
2026-06-15 Sale : show line 4 in the form 10b5-1 −5,064 $69.42 $351,547 33,965 D
2026-06-15 Sale : show line 5 in the form 10b5-1 −300 $70.62 $21,187 33,665 D
2026-06-15 Sale : show line 6 in the form 10b5-1 −947 $69.69 $65,996 32,718 D
Open-market sales · 7,947 sh · avg $69.28 · $550,607

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-15 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) −3,500 204,063 D
2026-06-15 Exercise or conversion : show line 8 in the form 10b5-1 Employee Warrant (right to buy) −3,500 175,492 D
Loading xslF345X06/form4.xml…